Syndax Pharmaceuticals Inc
SNDXCIK 0001395937 · Every Form 4 filed by insiders at this issuer.
Filings
10
Latest Feb 9, 2024
Unique insiders
10
Showing
10 of 10
Page 1
Top insiders
Most active reporters at Syndax Pharmaceuticals Inc
| Name | Roles | Filings |
|---|---|---|
| Gallagher Neil | Officer | 1 |
| Goldan Keith A. | Officer | 1 |
| Huber Martin H. Jr. | Director | 1 |
| Jarrett Jennifer | Director | 1 |
| Katkin Keith | Director | 1 |
| Legault Pierre | Director | 1 |
| Metzger Michael A | OfficerDirector | 1 |
| Meury William | Director | 1 |
| Morrison Briggs | Director | 1 |
| Podlesak Dennis | Director | 1 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 9, 2024 | Legault Pierre Director | A | 17,000 | $0.00 | $0 | |
| Feb 9, 2024 | Podlesak Dennis Director | A | 34,000 | $0.00 | $0 | |
| Feb 9, 2024 | Morrison Briggs Director | A | 17,000 | $0.00 | $0 | |
| Feb 9, 2024 | Meury William Director | A | 17,000 | $0.00 | $0 | |
| Feb 9, 2024 | Katkin Keith Director | A | 17,000 | $0.00 | $0 | |
| Feb 9, 2024 | Jarrett Jennifer Director | A | 17,000 | $0.00 | $0 | |
| Feb 9, 2024 | Huber Martin H. Jr. Director | A | 17,000 | $0.00 | $0 | |
| Feb 9, 2024 | Gallagher Neil President, Head of R&D | A | 34,688 | $0.00 | $0 | |
| Feb 9, 2024 | Goldan Keith A. Chief Financial Officer | J | 1,183 | $17.42 | $20,608 | |
| Feb 9, 2024 | Metzger Michael A Chief Executive Officer · Director | A | 107,250 | $0.00 | $0 |
Showing 1–10 of 10
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.